Showing results 1 to 2 of 2
Title | Author(s) | Issue Date | |
---|---|---|---|
A Phase IIIb open-label, single-arm study of afatinib in EGFR TKI-naïve patients with EGFRm+ NSCLC: An interim analysis. Proceeding/Conference:World Lung Cancer Conference, 2017 | 2017 | ||
PITX2C increases the stemness features of hepatocellular carcinoma cells by up-regulating key developmental factors in liver progenitor Journal:Journal of Experimental & Clinical Cancer Research | 2022 |